Welcome to Citeline's 2016 review of trends in pharmaceutical R&D. For around a quarter of a century now, Citeline's Ian Lloyd has been taking an annual look at the continuing drama which is pharma R&D.

In this paper, Lloyd looks at how pipeline as a whole has changed in the past twelve months and finds indicators of what the new year might bring. He adds his thoughts on the nominees for 2015’s Best Newcomer award when Citeline issues its review of the year’s New Active Substance launches as a supplement to this report, at the beginning of March 2016.

To download the report, click the PDF link at the top of the page.

For more information, please visit Citeline here.